Company registration number 05314236 (England and Wales)
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
CONTENTS
Page
Strategic report
1 - 5
Directors' responsibilities statement
6
Directors' report
7 - 8
Independent auditor's report
9 - 16
Statement of comprehensive income
17
Balance sheet
18
Statement of changes in equity
19
Notes to the financial statements
20 - 29
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
COMPANY INFORMATION
Directors
Mr A J Watson
Mrs G Birley-Smith
Mr J S Gordon
Mr S McGhee
Secretary
Resolis Limited
Company number
05314236
Registered office
Alder Castle
10 Noble Street
London
United Kingdom
EC2V 7JX
Auditor
BDO LLP
55 Baker Street
London
W1U 7EU
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

The directors present the strategic report for the year ended 31 December 2025.

 

Principal Activities and Fair Review of Business

The Company is principally engaged in providing financing to Healthcare Support (Newcastle) Limited (the “SPV”), a fellow subsidiary undertaking of Healthcare Support (Newcastle) Holdings Limited for the construction of new extensions to the Royal Victoria Infirmary and Freeman Hospital, on behalf of the Newcastle Upon Tyne Hospitals NHS Foundation Trust (the “Trust”). Financial close was achieved on 4 May 2005. The concession period is 38 years. The Company raised external and shareholder financing in the form of a bond, bank loans and loans from its parent company which it then lent to the SPV on substantially the same terms. The principal risk to the Company is the risk of potential Events of Default under the Finance Documents which gives the bond and loan lenders ("Majority Creditors") the right to demand amounts owed under the Finance Documents to be repaid in full. This risk is outlined in the following Going Concern section.

 

The Company continues to have a £115,000,000 in an index linked loan from the European Investment Bank and a £197,800,000 in index linked bond debt held by Bank of New York Mellon.

 

In March 2010 the Company drew down £24,607,000 of subordinated debt from Healthcare Support (Newcastle) Holdings Limited.

 

Going Concern

Nature of the Company

Healthcare Support (Newcastle) Finance PLC (the “Company”) is a special purpose vehicle (“SPV”) formed solely to act as a financing conduit for Healthcare Support (Newcastle) Limited (the “Operating SPV”), a fellow subsidiary undertaking with common directors. The Company raised bond and bank loan facilities from the bond and bank loan lenders (the “Majority Creditors”) and on-lent the proceeds to the Operating SPV on substantially the same terms, including the Events of Default provisions, under the finance documents governing those facilities (the “Finance Documents”). As the Company depends on the Operating SPV generating sufficient cash flows to meet its own obligations and covenants, its going concern assessment and cash flow forecasts are directly dependent on those of the Operating SPV.

 

Basis of Preparation

The financial statements are prepared on a going concern basis. The Company had technical Events of Default under the Finance Documents that were unwaived at the balance sheet date of 31 December 2025, and further technical Events of Default arose after that date (see Technical Events of Default below). At the date of approval of these financial statements, the Majority Creditors had not formally waived, or confirmed as remedied, the remaining technical Events of Default, such that technical Events of Default were continuing at that date. The Directors consider that this indicates the existence of a material uncertainty, as described below.

 

Service Performance and Settlement Agreements

During 2017 and 2018 the level of service provided by the Operating SPV’s principal subcontractor, Mitie FM Limited (formerly Interserve (Facilities Management) Limited) (the “Service Provider”), gave rise to Service Failure Points (“SFPs”) above threshold levels in certain Project Documents. This led to warning notices from the Newcastle upon Tyne Hospitals NHS Foundation Trust (the “Trust”) to the Operating SPV and triggered an Event of Default under the Finance Documents. Although SFP levels have since been relatively low, further Events of Default occurred in October 2021, December 2022, May 2023 and June 2023 in relation to a specific set of circumstances. The financial impact of service performance shortfalls is described in the going concern statement of the Operating SPV.

 

On 20 August 2025 a Settlement Agreement (“SA2”) was executed between all concerned parties. SA2 wiped clean all historic SFPs and financial deductions relating to the performance issues that gave rise to Events of Default, and all such Events of Default were formally waived and deemed remedied by the Majority Creditors during the year. Ventilation, electrical and fire matters, which have given rise to disputed SFPs and deductions, remain to be resolved; two further settlement agreements addressing these matters are being negotiated, and standstill agreements are in place for all outstanding issues.

 

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Going Concern (continued)

Parent Company Guarantee

On 15 March 2019 Interserve PLC, the former parent company of the Service Provider, entered administration, invalidating its parent company guarantee (“PCG”) and triggering an Event of Default. Mitie PLC acquired the Service Provider on 1 December 2020, and the replacement PCG from Mitie PLC executed during the year ended 31 December 2024 formally remedied that Event of Default.

Technical Events of Default

The Directors have considered all technical Events of Default, both those unwaived at 31 December 2025 and those arising after that date, as the position at the date of approval is relevant to the going concern assessment. The classification of borrowings in the balance sheet is determined by the position at 31 December 2025 only.

 

Unwaived at 31 December 2025:

1. Late submission of the September 2025 financial model.

2. Late delivery of the 2024 annual financial statements to the Majority Creditors.

3. Late filing and publication of the 2024 annual financial statements under the Companies Act 2006 and the Disclosure Guidance and Transparency Rules.

4. Entry into Major Repairs contracts, and acceptance of Variation VE754, without the prior consent of the Majority Creditors.

5. Account bank consent and waiver not executed (executed on 11 September 2026).

 

Arising after 31 December 2025:

6. Late delivery of the 2025 annual financial statements (due 29 June 2026).

7. Late submission of the March 2026 financial model.

8. Entry into further Major Repairs contracts without the prior consent of the Majority Creditors.

9. Expiry on 20 August 2026 of the waiver, granted in connection with SA2, of Events of Default relating to the ratings of the Bonds or the Project (the “Ratings Issues”), which remain unresolved and in respect of which the parties have reserved their rights.

 

Item 5 was resolved on 11 September 2026. A waiver and confirmation letter in respect of the remaining items has been negotiated with the Majority Creditors but had not been executed at the date of approval of these financial statements. Accordingly, technical Events of Default were continuing at the date of approval. The Directors do not consider that these reflect any deterioration in the underlying financial performance of the Operating SPV, and have received assurances that the Majority Creditors do not intend to exercise their rights in connection with them.

Lender Assurances and Cash Flow Forecasts

The Directors have discussed the current level of service, SA2, the further settlement agreements and the replacement PCG executed in 2024 with the Majority Creditors, who receive regular updates, and have received assurances that the Majority Creditors would not intend to exercise their rights to require immediate repayment if a future Event of Default occurred.

 

The Directors have prepared cash flow and covenant compliance forecasts for the Company and the Operating SPV covering at least 12 months from the date of approval of these financial statements. Taking account of severe but plausible downside scenarios, these indicate that the Company will have sufficient funds to meet its liabilities as they fall due and that no covenant breaches are forecast. Both the base case and the downside scenarios include estimated cash outflows for the remaining settlement agreements and assume that the Majority Creditors will not accelerate repayment as a result of any future Event of Default arising from the ongoing issues.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -

Classification of Liabilities – FRS 102

Because Events of Default existed at 31 December 2025, the Company did not have an unconditional right at that date to defer repayment of its borrowings for at least 12 months. Accordingly, the bond and bank loan, together with associated interest payable, are classified as current liabilities: £366,101,000 (2024: £367,653,000) that would otherwise be included in ‘Creditors: amounts due after more than one year’ is included in ‘Creditors: amounts due within one year’. This classification reflects the position at 31 December 2025 only.

 

Material Uncertainty – FRS 102 Disclosure

As technical Events of Default were continuing at the date of approval of these financial statements, the Majority Creditors were entitled at that date to exercise their rights under the Finance Documents, including to require immediate repayment, and the Company does not have the funds to repay the amounts outstanding if such repayment were demanded. Following SA2, the Majority Creditors cannot exercise these rights on performance-related grounds.

 

The Directors have a reasonable expectation, based on the assurances received, that the Majority Creditors will not exercise their rights in respect of the continuing technical Events of Default, that those Events of Default will be waived or remedied, and that the Majority Creditors would not require repayment if further Events of Default arose within at least 12 months from the date of approval. The standstill agreements mitigate the risk of service failure point breaches, and further settlement agreements are expected to be executed in the coming months. However, none of these outcomes is guaranteed, given that the waiver and confirmation letter has not been executed and the uncertainty that remains around the ongoing project issues.

 

The Company therefore remains dependent on the Majority Creditors not exercising their rights to demand repayment. In accordance with FRS 102 paragraph 3.9, this dependence indicates the existence of a material uncertainty which may cast significant doubt on the Company’s ability to continue as a going concern and, therefore, the Company may be unable to realise its assets and discharge its liabilities in the normal course of business.

 

Conclusion

Based on the foregoing, the Directors believe it remains appropriate to prepare the financial statements on a going concern basis. The financial statements do not include any adjustments that would result from the basis of preparation being inappropriate.

Principal Risks and Uncertainties

 

Interest rate risk

The Company is exposed to interest rate risk on bank balances with floating interest rates, however the directors do not consider this exposure to be significant.

 

The guaranteed secured loan and bond, and the unsecured subordinated loan notes, all have fixed rates until 2038, 2041 and when the directors deem repayable respectively, thus there is no interest rate risk associated with these financial liabilities (senior debt is index linked) therefore directors are comfortable this does not affect the ability of the Company to continue as a going concern.

 

Inflation Risk

The Company has senior debt borrowings which are index linked to RPI (all items). The Company partially mitigates this RPI risk by having an index linked unitary contract with the Newcastle Upon Tyne Hospitals NHS Foundation Trust, thereby partially mitigating inflationary risk therefore the directors are comfortable inflation risk will not affect the Group's ability to continue as a going concern.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
Financial performance and financial position

The Company made a pre-tax profit of £40,000 (2024: £40,000) for the year.

 

Interest receivable has increased to £31,699,000 (2024: £26,433,000) for the year. Interest is charged to fellow subsidiary, Healthcare Support (Newcastle) Limited, to cover the cost of the loan and bond interest payable, plus a mark-up of 0.5%. As such, the interest receivable by the Company will be directly affected by fluctuations in indexation as the underlying debt is index-linked. There is a compensating increase in interest payable to £31,659,000 (2024: £26,393,000).

 

At 31 December 2025 the Company had net assets of £672,000 (2024: net assets of £642,000).

 

Loan interest payable, which is also index-linked, has increased to £24,150,000 (2024: £19,856,000) in the year due to the continuing repayment of the Company's borrowings and due to an increase in indexation. Interest payable on the subordinated loan has increased to £7,509,000 (2024: £6,537,000) due to the impact of compounded interest unpaid from previous years.

 

During the year the Company has not repaid any of the subordinated debt loan.

Key performance indicators

The directors have modelled the anticipated financial outcome of the project across the term of the contract up to the end of the concession. The directors monitor actual performance against this anticipated performance. As discussed above the Company’s performance as at 31 December 2025 against this measure was considered satisfactory.

Section 172 Companies Act 2006 Statement

The Directors have a duty to promote the success of the Company for the benefit of the shareholders as a whole and to describe how this duty has been performed with regard to those matters set out in section 172 of the Companies Act 2006 (“section 172”).

 

The Directors have identified the Company’s main stakeholders as the following:

 

i.    The Company’s shareholders, bondholders and majority creditors

Principal considerations of the board are whether the investment objective of the Company is meeting shareholder and bondholder expectations and how the manager implements the objective. These are discussed at all board meetings, which are held regularly throughout the year. The board also attends regular shareholder and bondholder briefing meetings to ensure that shareholder and bondholder engagement is optimised.

 

ii.    The manager

The delivery by the manager of its services is fundamental to the long-term success of the Company. The board seeks to engage regularly with the manager through a number of forums, including at board meetings, portfolio briefings and through engagement with the manager’s senior leadership team. Regular reporting is provided to the board by the manager, which will alert the board to changes to regulation or market practice, which will inform the board’s decision making.

 

Throughout the year the board has made due consideration during its discussions and decision-making of the matters set out in section 172 and below is a description of how the directors have had regard to these matters when performing their duties:

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -

Section 172 Companies Act 2006 statement (continued)

(a)    The likely consequences of any decision in the long term.

The Company has outsourced the management of the Company to Resolis Limited (“Resolis”), the manager. Resolis took over the management services of the Company from Vercity Social Infrastructure (UK) Limited on 1 July 2022. The delivery by the manager of its services is fundamental to the long-term success of the Company. The board seeks to engage regularly with the manager through a number of forums, including at board meetings, portfolio briefings and through engagement with the manager’s senior leadership team. Regular reporting is provided to the board by the manager, which will alert the board to changes to regulation or market practice, which will inform the board’s decision making.

 

(b)    The interests of the Company’s employees.

As an externally managed Company, the Company’s activities are all outsourced and therefore it does not have any employees. The Company does however, pay due regard to the interests and safety of all those engaged by contractors to the Company to perform services on its behalf.

 

(c)    The need to foster the Company’s business relationships with suppliers, customers and others.

The Company is committed to upholding the underlying principle of PFI of working in partnerships with all parties to the arrangement. As noted above, the Company has policies and procedures to ensure regular communication is maintained between the parties.

 

(d)    The impact of the Company’s operations on the community and the environment.

The Company has very limited direct impact on the environment. Notwithstanding that the Company is committed to minimising environmental disruption from its activities. The board upholds the Company’s environmental policy in all its activities and requires all parties to the arrangement to do the same. The board recognises that the Company is a key partner in the delivery of public infrastructure and encourages its partners in considering and delivering Environmental, Social and Governance (ESG) values and initiatives to achieve socially responsible investing.

 

(e)    The desirability of the Company maintaining a reputation for high standards of business conduct.

The Company is committed, in its day to day operations and dealings with all affiliates to uphold the highest standard of business conduct and integrity. The directors are not responsible for setting a “business culture” in the traditional sense, but are committed to understanding the culture of the manager and service providers and raise any concerns in this regard if necessary.

 

(f)    The need to act fairly between members of the Company

The members of the Company are represented at board meetings by their appointed director(s). Conflicts on matters to be discussed are identified at each meeting of the board. Directors representing a member with a conflict of interest may therefore be excluded from any discussion or vote in regards to it.

 

The Directors are cognisant of their duty under s172 in their deliberation as a board on all matters. Decisions made by the board take into account the interests of all the Company’s key stakeholders and reflect the board’s belief that the long term sustainable success of the Company is linked directly to its key stakeholders.

On behalf of the board

Mr A J Watson
Director
26 October 2026
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -

The directors present their annual report and financial statements for the year ended 31 December 2025.

Principal activities

The principal activity of the Company continued to be that of providing financing to Healthcare Support (Newcastle) Limited.

Results and dividends

The results for the year are set out on page 17.

No ordinary dividends were paid (2024: nil). The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr S McGhee
(Appointed 12 May 2025)
Mr A J Watson
Mrs G Birley-Smith
Mr J S Gordon
Mr J McDonagh
(Resigned 12 May 2025)
Directors' interests

No Director has any interest in the issued share capital of the Company.

Financial risk management objectives and policies
Liquidity risk

Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities. The Company aims to mitigate this risk by closely monitoring the timing of cash flows within the Company.

Interest rate risk

The Company is exposed to interest rate risk on bank balances with floating interest rates, however the directors do not consider this exposure to be significant.

 

The guaranteed secured loan and bond, and the unsecured subordinated loan notes, all have fixed rates until 2038, 2041 and when directors deem repayable respectively, thus there is no interest rate risk associated with these financial liabilities (senior debt is index linked).

Credit risk

The Company's credit risk is attributable to its receivables with Healthcare Support (Newcastle) Limited from cashflow it receives from its client, the Newcastle Upon Tyne NHS Foundation Trust. In the opinion of the board of directors this risk is limited as the receivables are with Newcastle Upon Tyne Hospitals NHS Foundation Trust and guaranteed by the Department of Health.

Inflation risk

The Company has issued a public bond which is subject to indexation in line with RPI. The Company mitigates this RPI risk by having an inter-company loan with Healthcare Support (Newcastle) Limited, a fellow group undertaking, which tracks the movement in RPI in bank financed debt.

Post reporting date events

The Company has no post reporting date events to report.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
Future developments

Details of future developments and the directors' statement can be found in the strategic report on pages 1 to 5 and form part of this report by cross-reference.

Auditor

BDO LLP has informed the directors that it intends to resign as auditor of the Company once it has completed its audit of the financial statements for the year ended 31 December 2025. The directors are in the process of selecting a successor auditor. They will appoint one to fill the resulting casual vacancy, in accordance with section 485(3) of the Companies Act 2006.

Corporate governance

Disclosure Transparency Rules require Public Listed Entities to have a body which is responsible, as a minimum, for monitoring the financial reporting process, monitoring the internal controls and risk management of the Company and monitoring the statutory audit and the independence of the statutory auditor. The Board considers it adequately performs the equivalent functions, roles and responsibilities that such a body is expected to undertake. The primary duties of the body, which are fulfilled by the Board of Directors are to:

Energy and carbon report

As the Company has not consumed more than 40,000 kWh of energy in this reporting period, it qualifies as a low energy user under these regulations and is not required to report on its emissions, energy consumption or energy efficiency activities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the Company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the Company’s auditor is aware of that information.

On behalf of the board
Mr A J Watson
Director
26 October 2026
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
- 9 -
Opinion

In our opinion the financial statements:

 

We have audited the financial statements of Healthcare Support (Newcastle) Finance Plc (the ‘Company’) for the year ended 31 December 2025 which comprise of the following:

 

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs

(UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

 

Independence

 

We remain independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard as applied to listed public interest entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements. The non-audit services prohibited by the FRC’s Ethical Standard were not provided to the Company and we remain independent of the Company in conducting our audit.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC (CONTINUED)
- 10 -

Material Uncertainty relating to going concern

We draw attention to Note 1.2 to the financial statement, which indicates that the Company is dependent on the Majority Creditors not exercising their rights to demand repayment of the amounts owed due to the events of defaults which is not guaranteed. As stated in Note 1.2, these events or conditions, along with other matters as set forth in Note 1.2, indicate a material uncertainty exists that may cast significant doubt on the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that would result if the Company were unable to continue as a going concern. Our opinion is not modified in respect of this matter.

 

Given the conditions and uncertainties disclosed in Note 1.2, we determined going concern to be a key audit matter.

 

Our evaluation of the Directors’ assessment of the Company’s ability to continue to adopt the going concern basis of accounting, and in response to the key audit matter included:

 

In auditing the financial statements, we have concluded that the Directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Our responsibilities and the responsibilities of the Directors with respect to going concern are described in the relevant sections of this report.

Overview

 

Key audit matters

 

2025

2024

Recoverability of amounts owed by group undertaking

Yes

Yes

Going concern

Yes

No*

*Going concern was not a key audit matter in the prior year due to the matter described in the basis for disclaimer of opinion section of our auditor’s report for the year ended 31 December 2024.        

 

 

Materiality

 

Company financial statements as a whole

£4.3m (2024: £4.2m) based on 1% of total assets (2024: 1% of total assets).

 

 

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC (CONTINUED)
- 11 -

An overview of the scope of our audit

Our audit was scoped by obtaining an understanding of the Company and its environment, including the Company’s system of internal control, and assessing the risks of material misstatement in the financial statements. We also addressed the risk of management override of internal controls, including assessing whether there was evidence of bias by the Directors that may have represented a risk of material misstatement.

 

Key audit matters

 

Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the financial statements of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) that we identified, including those which had the greatest effect on the overall audit strategy, the allocation of resources in the audit, and directing the efforts of the engagement team. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

 

In addition to the matter described in the material uncertainty related to going concern section, we have determined the matters described below to be the key audit matters to be communicated in our report.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC (CONTINUED)
- 12 -

Key audit matter

How the scope of our audit responded to the risk

Recoverability of amounts owed by group undertakings

 

(Note 1.3 Financial

Instruments, and Note 8

Debtors)

The carrying amount of the Company’s amounts owed by group undertakings, held at amortised cost less impairment represents 100% of the Company’s total assets.

 

The recoverability of amounts due is directly linked to the ability of the counterparty to continue generating cash flows which can be used to repay this balance

 

The recoverability of the balance is a key audit matter given the magnitude of the balance and judgement involved in assessing the recoverability.

 

Our audit work included the following:

  • We evaluated management's impairment assessment for intercompany balances, including the reasonableness of assumptions used in the cash flow forecasts of the counterparty.

  • We assessed the financial performance of the counterparty and its ability to generate sufficient future cash flows to support the recoverability of intercompany balances.

  • We evaluated the potential impact of operational issues, contractual disputes and wider economic developments on the counterparty's forecast performance and projected outcomes.

  • We challenged management's estimates of future lifecycle expenditure, including assessing the reasonableness of the long-term lifecycle plan, reviewing lifecycle budgets against historical expenditure and considering the condition of the underlying assets.

  • We compared the intercompany balances to the underlying net assets and forecast cash flows of the counterparty to assess whether any impairment is required.

  • We assessed the adequacy of the related financial statement disclosures, including key assumptions, judgements and estimation uncertainty.

Key observations:

Based on the work performed, we concluded management’s assessment of the recoverability of the amounts owed by group undertakings to be reasonable.

 

 

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC (CONTINUED)
- 13 -
Our application of materiality

We apply the concept of materiality both in planning and performing our audit, and in evaluating the effect of misstatements. We consider materiality to be the magnitude by which misstatements, including omissions, could influence the economic decisions of reasonable users that are taken on the basis of the financial statements.

 

In order to reduce to an appropriately low level the probability that any misstatements exceed materiality, we use a lower materiality level, performance materiality, to determine the extent of testing needed. Importantly, misstatements below these levels will not necessarily be evaluated as immaterial as we also take account of the nature of identified misstatements, and the particular circumstances of their occurrence, when evaluating their effect on the financial statements as a whole.

 

Based on our professional judgement, we determined materiality for the financial statements as a whole and performance materiality as follows:

 

 

Company financial statements

 

2025

2024

Materiality

£4.3m

£4.2m

Basis for determining materiality

1% of total assets

1% of total assets

Rationale for the benchmark applied

Given the principal activities of the Company our judgement was that the users of the financial statements would be most concerned with the recoverability of the amounts owed by group undertakings. We therefore considered the Company to be asset driven and total assets to be the most

appropriate basis for determining materiality.

Performance materiality

£3.2m

£3.1m

Basis for determining performance materiality

75% of Materiality

75% of Materiality

Rationale for the percentage applied to performance materiality

The level of performance materiality applied was set after having considered a number of factors including expected level of likely misstatements based on past experience and managements attitude towards proposed adjustments.

 

Reporting threshold

 

We agreed with the Audit Committee that we would report to them all individual audit differences in excess of £0.2m (2024: £0.1m). We also agreed to report differences below this threshold that, in our view, warranted reporting on qualitative grounds.

Other information

The Directors are responsible for the other information. The other information comprises the information included in the Annual Report and Financial Statements, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC (CONTINUED)
- 14 -

Other Companies Act 2006 reporting

Based on the responsibilities described below and our work performed during the course of the audit, we are required by the Companies Act 2006 and ISAs (UK) to report on certain opinions and matters as described below.

 

Strategic report and Directors’ report

 

In our opinion, based on the work undertaken in the course of the audit:

  • the information given in the Strategic report and the Directors’ report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the Strategic report and the Directors’ report have been prepared in accordance with applicable legal requirements.

 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic report or the Directors’ report.

 

Matters on which we are required to report by exception

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

  • adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  • the financial statements are not in agreement with the accounting records and returns; or

  • certain disclosures of Directors’ remuneration specified by law are not made; or

  • we have not received all the information and explanations we require for our audit.

 

 

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of Directors

As explained more fully in the Directors’ responsibilities statement, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the Directors are responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC (CONTINUED)
- 15 -
Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the Company and management.

Extent to which the audit was capable of detecting irregularities, including fraud

 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

 

Non-compliance with laws and regulations

 

Based on:

we considered the significant laws and regulations to be the applicable accounting framework, UK tax legislation, VAT legislation, UK listing rules and the Companies Act 2006.

 

The Company is also subject to laws and regulations where the consequence of non-compliance could have a material effect on the amount or disclosures in the financial statements, for example through the imposition of fines or litigations. We identified such laws and regulations to be the health and safety legislation, Bribery Act and Data Protection Act.

 

Our procedures in respect of the above included:

Irregularities including fraud

 

We assessed the susceptibility of the financial statements to material misstatement, including fraud. Our risk assessment procedures included:

 

Based on our risk assessment, we considered the area’s most susceptible to fraud to be management override of controls and management bias regarding the accounting estimates and judgements over the recoverability of amounts owed by group undertakings.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC (CONTINUED)
- 16 -

Our procedures in respect of the above included:

 

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, who were all deemed to have appropriate competence and capabilities, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the Company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

 

In due course, as required by the Financial Conduct Authority Disclosure Guidance and Transparency Rule 4.1.15R - 4.1.18R, these financial statements will form part of the Electronic Format Annual Financial Report filed on the National Storage Mechanism of the FCA in accordance with DTR 4.1.15R – DTR 4.1.18R. This auditor’s report provides no assurance

Jason Homewood (Senior Statutory Auditor)
For and on behalf of BDO LLP, Statutory Auditor
London, UK
26 October 2026
BDO LLP is a limited liability partnership registered in England and Wales (with registered number OC305127).
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
- 17 -
2025
2024
Notes
£000
£000
Interest receivable and similar income
6
31,699
26,433
Interest payable and similar expenses
5
(31,659)
(26,393)
Profit before taxation
40
40
Tax on profit
7
(10)
(10)
Profit and total comprehensive income for the financial year
30
30

The Statement of Comprehensive Income has been prepared on the basis that all operations are continuing operations.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 18 -
2025
2024
Notes
£000
£000
£000
£000
Current assets
Debtors falling due after more than one year
8
414,706
408,507
Debtors falling due within one year
8
18,975
20,678
433,681
429,185
Creditors: amounts falling due within one year
9
(433,009)
(428,543)
Net current assets
672
642
Capital and reserves
Called up share capital
11
50
50
Profit and loss reserves
622
592
Total equity
672
642
The financial statements were approved by the board of directors and authorised for issue on 26 October 2026 and are signed on its behalf by:
Mr A J Watson
Director
Company Registration No. 05314236
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 19 -
Share capital
Profit and loss account
Total
£000
£000
£000
Balance at 1 January 2024
50
562
612
Year ended 31 December 2024:
Profit and total comprehensive income for the financial year
-
30
30
Balance at 31 December 2024
50
592
642
Year ended 31 December 2025:
Profit and total comprehensive income for the financial year
-
30
30
Balance at 31 December 2025
50
622
672
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 20 -
1
Accounting policies
Company information

Healthcare Support (Newcastle) Finance Plc is a public company limited by shares incorporated in England and Wales. The registered office is Alder Castle, 10 Noble Street, London, United Kingdom, EC2V 7JX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in pound sterling, which is the functional and presentational currency of the Company. Monetary amounts in these financial statements are rounded to the nearest £000.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This Company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this Company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The Company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the Company are consolidated in the financial statements of Healthcare Support (Newcastle) Holdings Limited. These consolidated financial statements are available from Companies House.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 21 -
1.2
Going concern

 

Nature of the Companytrue

Healthcare Support (Newcastle) Finance PLC (the “Company”) is a special purpose vehicle (“SPV”) formed solely to act as a financing conduit for Healthcare Support (Newcastle) Limited (the “Operating SPV”), a fellow subsidiary undertaking with common directors. The Company raised bond and bank loan facilities from the bond and bank loan lenders (the “Majority Creditors”) and on-lent the proceeds to the Operating SPV on substantially the same terms, including the Events of Default provisions, under the finance documents governing those facilities (the “Finance Documents”). As the Company depends on the Operating SPV generating sufficient cash flows to meet its own obligations and covenants, its going concern assessment and cash flow forecasts are directly dependent on those of the Operating SPV.

 

Basis of Preparation

The financial statements are prepared on a going concern basis. The Company had technical Events of Default under the Finance Documents that were unwaived at the balance sheet date of 31 December 2025, and further technical Events of Default arose after that date (see Technical Events of Default below). At the date of approval of these financial statements, the Majority Creditors had not formally waived, or confirmed as remedied, the remaining technical Events of Default, such that technical Events of Default were continuing at that date. The Directors consider that this indicates the existence of a material uncertainty, as described below.

 

Service Performance and Settlement Agreements

During 2017 and 2018 the level of service provided by the Operating SPV’s principal subcontractor, Mitie FM Limited (formerly Interserve (Facilities Management) Limited) (the “Service Provider”), gave rise to Service Failure Points (“SFPs”) above threshold levels in certain Project Documents. This led to warning notices from the Newcastle upon Tyne Hospitals NHS Foundation Trust (the “Trust”) to the Operating SPV and triggered an Event of Default under the Finance Documents. Although SFP levels have since been relatively low, further Events of Default occurred in October 2021, December 2022, May 2023 and June 2023 in relation to a specific set of circumstances. The financial impact of service performance shortfalls is described in the going concern statement of the Operating SPV.

 

On 20 August 2025 a Settlement Agreement (“SA2”) was executed between all concerned parties. SA2 wiped clean all historic SFPs and financial deductions relating to the performance issues that gave rise to Events of Default, and all such Events of Default were formally waived and deemed remedied by the Majority Creditors during the year. Ventilation, electrical and fire matters, which have given rise to disputed SFPs and deductions, remain to be resolved; two further settlement agreements addressing these matters are being negotiated, and standstill agreements are in place for all outstanding issues.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 22 -

Going concern (continued)

Parent Company Guarantee

On 15 March 2019 Interserve PLC, the former parent company of the Service Provider, entered administration, invalidating its parent company guarantee (“PCG”) and triggering an Event of Default. Mitie PLC acquired the Service Provider on 1 December 2020, and the replacement PCG from Mitie PLC executed during the year ended 31 December 2024 formally remedied that Event of Default.

Technical Events of Default

The Directors have considered all technical Events of Default, both those unwaived at 31 December 2025 and those arising after that date, as the position at the date of approval is relevant to the going concern assessment. The classification of borrowings in the balance sheet is determined by the position at 31 December 2025 only.

Unwaived at 31 December 2025:

1. Late submission of the September 2025 financial model.

2. Late delivery of the 2024 annual financial statements to the Majority Creditors.

3. Late filing and publication of the 2024 annual financial statements under the Companies Act 2006 and the Disclosure Guidance and Transparency Rules.

4. Entry into Major Repairs contracts, and acceptance of Variation VE754, without the prior consent of the Majority Creditors.

5. Account bank consent and waiver not executed (executed on 11 September 2026).

Arising after 31 December 2025:

6. Late delivery of the 2025 annual financial statements (due 29 June 2026).

7. Late submission of the March 2026 financial model.

8. Entry into further Major Repairs contracts without the prior consent of the Majority Creditors.

9. Expiry on 20 August 2026 of the waiver, granted in connection with SA2, of Events of Default relating to the ratings of the Bonds or the Project (the “Ratings Issues”), which remain unresolved and in respect of which the parties have reserved their rights.

Item 5 was resolved on 11 September 2026. A waiver and confirmation letter in respect of the remaining items has been negotiated with the Majority Creditors but had not been executed at the date of approval of these financial statements. Accordingly, technical Events of Default were continuing at the date of approval. The Directors do not consider that these reflect any deterioration in the underlying financial performance of the Operating SPV, and have received assurances that the Majority Creditors do not intend to exercise their rights in connection with them.

Lender Assurances and Cash Flow Forecasts

The Directors have discussed the current level of service, SA2, the further settlement agreements and the replacement PCG executed in 2024 with the Majority Creditors, who receive regular updates, and have received assurances that the Majority Creditors would not intend to exercise their rights to require immediate repayment if a future Event of Default occurred.

 

The Directors have prepared cash flow and covenant compliance forecasts for the Company and the Operating SPV covering at least 12 months from the date of approval of these financial statements. Taking account of severe but plausible downside scenarios, these indicate that the Company will have sufficient funds to meet its liabilities as they fall due and that no covenant breaches are forecast. Both the base case and the downside scenarios include estimated cash outflows for the remaining settlement agreements and assume that the Majority Creditors will not accelerate repayment as a result of any future Event of Default arising from the ongoing issues.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 23 -

Classification of Liabilities – FRS 102

Because Events of Default existed at 31 December 2025, the Company did not have an unconditional right at that date to defer repayment of its borrowings for at least 12 months. Accordingly, the bond and bank loan, together with associated interest payable, are classified as current liabilities: £366,101,000 (2024: £363,355,000) that would otherwise be included in ‘Creditors: amounts due after more than one year’ is included in ‘Creditors: amounts due within one year’. This classification reflects the position at 31 December 2025 only.

 

Material Uncertainty – FRS 102 Disclosure

As technical Events of Default were continuing at the date of approval of these financial statements, the Majority Creditors were entitled at that date to exercise their rights under the Finance Documents, including to require immediate repayment, and the Company does not have the funds to repay the amounts outstanding if such repayment were demanded. Following SA2, the Majority Creditors cannot exercise these rights on performance-related grounds.

 

The Directors have a reasonable expectation, based on the assurances received, that the Majority Creditors will not exercise their rights in respect of the continuing technical Events of Default, that those Events of Default will be waived or remedied, and that the Majority Creditors would not require repayment if further Events of Default arose within at least 12 months from the date of approval. The standstill agreements mitigate the risk of service failure point breaches, and further settlement agreements are expected to be executed in the coming months. However, none of these outcomes is guaranteed, given that the waiver and confirmation letter has not been executed and the uncertainty that remains around the ongoing project issues.

 

The Company therefore remains dependent on the Majority Creditors not exercising their rights to demand repayment. In accordance with FRS 102 paragraph 3.9, this dependence indicates the existence of a material uncertainty which may cast significant doubt on the Company’s ability to continue as a going concern and, therefore, the Company may be unable to realise its assets and discharge its liabilities in the normal course of business.

 

Conclusion

Based on the foregoing, the Directors believe it remains appropriate to prepare the financial statements on a going concern basis. The financial statements do not include any adjustments that would result from the basis of preparation being inappropriate.

1.3
Financial instruments

The Company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the Company's balance sheet when the Company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 24 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except those investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the Company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Other financial liabilities

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 25 -
Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.4
Equity instruments

Equity instruments issued by the Company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

1.5
Taxation

The tax expense represents tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit may differ from net profit as reported in the statement of comprehensive income because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The Company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Recoverability of amounts owed by group undertakings

The amounts owed by group undertakings are due from Healthcare Support (Newcastle) Limited. The recoverability of amounts due is directly linked to the ability of Healthcare Support (Newcastle) Limited to continue generating cash flows which can be used to repay this balance.

 

The directors have reviewed long-term forecasts of the performance of Healthcare Support (Newcastle) Limited and consider the amounts recoverable.

3
Auditor's remuneration
2025
2024
Fees payable to the Company's auditor and associates:
£000
£000
For audit services
Audit of the financial statements of the Company
22
11

The fees payable of £22,000 (2024: £11,000) to the Company's auditor for the audit of the Company's annual accounts is borne by Healthcare Support (Newcastle) Limited, who will not seek reimbursement.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 26 -
4
Employees

The average monthly number of persons (including directors) employed by the company during the year was: 0 (2024: 0).

 

5
Interest payable and similar expenses
2025
2024
£000
£000
Interest on bonds and loans
24,150
19,856
Interest payable to parent undertakings
7,509
6,537
31,659
26,393
6
Interest receivable and similar income
2025
2024
£000
£000
Interest income
Interest receivable from group companies
31,699
26,433
7
Taxation
2025
2024
£000
£000
Current tax
UK corporation tax on profits for the current period
10
10

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£000
£000
Profit before taxation
40
40
Expected tax charge arising on group relief payment based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
10
10
Taxation charge in the financial statements
10
10
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 27 -
8
Debtors
2025
2024
Amounts falling due within one year:
£000
£000
Amounts owed by group undertakings
18,975
20,678
2025
2024
Amounts falling due after more than one year:
£000
£000
Amounts owed by group undertakings
414,706
408,507
Total debtors
433,681
429,185

Amounts owed by group undertakings are amounts due from a fellow subsidiary, Healthcare Support (Newcastle) Limited, and is largely external debt raised by the Company and lent-on to the group undertaking.

 

Also, included within amounts owed by group undertakings is £24,337,000 (2024: £24,337,000) of principal borrowing (see note 10) and £40,418,000 (2024: £34,510,000) of accrued interest in respect of the subordinated debt lent-on to fellow subsidiary, Healthcare Support (Newcastle) Limited.

9
Creditors: amounts falling due within one year
2025
2024
Notes
£000
£000
Bank loans and bonds
10
366,101
367,653
Amounts owed to parent undertaking
64,755
58,847
Group relief owed to group undertakings
44
33
Bank loan accrued interest
2,109
2,010
433,009
428,543

As at 31 December 2025 and at 31 December 2024, there were Events of Default subsisting pursuant to the Company's finance documents and the Company's lenders had not formally waived or deemed remedied those Events of Default (refer to Going Concern note 1.2 for further details). Consequently, the Company's loans, bonds and amounts owed to parent undertaking are classified as due within one year in the balance sheet.

 

Included within amounts owed to parent undertakings is £24,337,000 (2024: £24,337,000) of principal borrowing (see note 10) and £40,418,000 (2024: £34,510,000) of accrued interest. Amounts due to parent undertakings is subordinate to the bank loans and bonds.

HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 28 -
10
Bank loans and bonds
2025
2024
£000
£000
Bank loans and bonds
366,101
367,653
Loans from parent undertakings
24,337
24,337
390,438
391,990
Payable within one year
390,438
391,990
390,438
391,990

The Company originally had a publicly offered bond held by Royal Bank of Canada for £197.8 million and a loan with European Investment Bank (EIB) of £115 million. On 7 April 2014, the Principal Paying Agency Agreement novated from the Royal Bank of Canada to the Bank of New York Mellon, London Branch. In line with this bond, the Company also has the capacity to draw a further £40 million of variations bonds if required, this has not been drawn upon to date. The public bond and loan debt are repayable in instalments based on an agreed percentage amount of the total facilities per annum over the next 16 years and 13 years respectively, subject to the right of the lenders to require immediate repayment should the company incur an Event of Default.

 

Interest on the public bond is fixed at 2.187% per annum and interest on the EIB loan is fixed at 2.1492% per annum (coupon of 1.9592% and margin of 0.19%). Both the public bond and EIB loan are index-linked by RPI (all items).

 

In addition, Healthcare Support (Newcastle) Holdings Limited has provided a credit facility of £24,607,000; this was drawn down in March 2010. The facility accrues interest at an agreed rate not exceeding 12% per annum. This facility is subordinate to the bond and bank loan facilities. Accrued at the balance sheet date and included within amounts owed to parent undertakings in respect of this is £24,337,000 (2024: £24,337,000) of principal borrowing and £40,418,000 (2024: £34,510,000) of accrued interest (see note 9). Interest is also accrued on unpaid interest.

 

The Company has on lent the proceeds of the bond, loan and borrowings from its parent to Healthcare Support (Newcastle) Limited and charges interest to Healthcare Support (Newcastle) Limited at a 0.5% mark-up on the same terms as it is charged by EIB and Bank of New York Mellon.

 

11
Share capital and reserves
2025
2024
2025
2024
Ordinary share capital
Number
Number
£000
£000
Issued and fully paid
Ordinary shares of £1 each
50,000
50,000
50
50
Reserves
The company's other reserves are as follows:
The profit and loss account represents cumulative profits or losses net of dividends.
HEALTHCARE SUPPORT (NEWCASTLE) FINANCE PLC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 29 -
12
Ultimate controlling party

The Company's immediate parent company is Healthcare Support (Newcastle) Holdings Limited, which is incorporated in the United Kingdom, registered at 10 Noble Street, London, United Kingdom, EC2V 7JX. The smallest and largest group in which its results are consolidated is Healthcare Support (Newcastle) Holdings Limited. Copies of the consolidated accounts are available from Companies House, Crown Way, Cardiff, CF14 8UZ. Healthcare Support (Newcastle) Holdings Limited is a joint venture between Palio (No 15) Limited (18.75%) and Innisfree Nominees Limited acting in its capacity as nominee on behalf of Innisfree PFI Secondary Partners 1 LLP (81.25%). Both of these companies are incorporated in the United Kingdom and registered in England and Wales. The directors consider there to be no ultimate controlling party or ultimate parent company.

2025-12-312025-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.300Mr A WatsonMrs G Birley-SmithJ S GordonMr J M McDonaghResolis Limited0053142362025-01-012025-12-3105314236bus:CompanySecretary12025-01-012025-12-3105314236bus:Director12025-01-012025-12-3105314236bus:Director22025-01-012025-12-3105314236bus:Director32025-01-012025-12-3105314236bus:Director42025-01-012025-12-3105314236bus:RegisteredOffice2025-01-012025-12-31053142362025-12-31053142362024-01-012024-12-3105314236core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3105314236core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3105314236core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3105314236core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-31053142362024-12-3105314236core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3105314236core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3105314236core:ShareCapital2025-12-3105314236core:ShareCapital2024-12-3105314236core:RetainedEarningsAccumulatedLosses2025-12-3105314236core:RetainedEarningsAccumulatedLosses2024-12-3105314236core:ShareCapital2023-12-3105314236core:RetainedEarningsAccumulatedLosses2023-12-31053142362023-12-3105314236core:ShareCapitalOrdinaryShareClass12025-12-3105314236core:ShareCapitalOrdinaryShareClass12024-12-3105314236core:UKTax2025-01-012025-12-3105314236core:UKTax2024-01-012024-12-3105314236core:AfterOneYear2025-12-3105314236core:AfterOneYear2024-12-3105314236core:CurrentFinancialInstruments2025-12-3105314236core:CurrentFinancialInstruments2024-12-3105314236bus:OrdinaryShareClass12025-01-012025-12-3105314236bus:OrdinaryShareClass12025-12-3105314236bus:OrdinaryShareClass12024-12-3105314236bus:PrivateLimitedCompanyLtd2025-01-012025-12-3105314236bus:FRS1022025-01-012025-12-3105314236bus:Audited2025-01-012025-12-3105314236bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP